Cyclical aggregation extends in vitro expansion potential of human mesenchymal stem cells

Abstract Mesenchymal stem cell (MSC)-based therapy has shown great promises in various animal disease models. However, this therapeutic potency has not been well claimed when applied to human clinical trials. This is due to both the availability of MSCs at the time of administration and lack of viab...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Brent M. Bijonowski, Xuegang Yuan, Richard Jeske, Yan Li, Samuel C. Grant
Formato: article
Lenguaje:EN
Publicado: Nature Portfolio 2020
Materias:
R
Q
Acceso en línea:https://doaj.org/article/482015429f474ea69540a7f3390f307c
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:482015429f474ea69540a7f3390f307c
record_format dspace
spelling oai:doaj.org-article:482015429f474ea69540a7f3390f307c2021-12-02T12:33:54ZCyclical aggregation extends in vitro expansion potential of human mesenchymal stem cells10.1038/s41598-020-77288-42045-2322https://doaj.org/article/482015429f474ea69540a7f3390f307c2020-11-01T00:00:00Zhttps://doi.org/10.1038/s41598-020-77288-4https://doaj.org/toc/2045-2322Abstract Mesenchymal stem cell (MSC)-based therapy has shown great promises in various animal disease models. However, this therapeutic potency has not been well claimed when applied to human clinical trials. This is due to both the availability of MSCs at the time of administration and lack of viable expansion strategies. MSCs are very susceptible to in vitro culture environment and tend to adapt the microenvironment which could lead to cellular senescence and aging. Therefore, extended in vitro expansion induces loss of MSC functionality and its clinical relevance. To combat this effect, this work assessed a novel cyclical aggregation as a means of expanding MSCs to maintain stem cell functionality. The cyclical aggregation consists of an aggregation phase and an expansion phase by replating the dissociated MSC aggregates onto planar tissue culture surfaces. The results indicate that cyclical aggregation maintains proliferative capability, stem cell proteins, and clonogenicity, and prevents the acquisition of senescence. To determine why aggregation was responsible for this phenomenon, the integrated stress response pathway was probed with salubrial and GSK-2606414. Treatment with salubrial had no significant effect, while GSK-2606414 mitigated the effects of aggregation leading to in vitro aging. This method holds the potential to increase the clinical relevance of MSC therapeutic effects from small model systems (such as rats and mice) to humans, and may open the potential of patient-derived MSCs for treatment thereby removing the need for immunosuppression.Brent M. BijonowskiXuegang YuanRichard JeskeYan LiSamuel C. GrantNature PortfolioarticleMedicineRScienceQENScientific Reports, Vol 10, Iss 1, Pp 1-10 (2020)
institution DOAJ
collection DOAJ
language EN
topic Medicine
R
Science
Q
spellingShingle Medicine
R
Science
Q
Brent M. Bijonowski
Xuegang Yuan
Richard Jeske
Yan Li
Samuel C. Grant
Cyclical aggregation extends in vitro expansion potential of human mesenchymal stem cells
description Abstract Mesenchymal stem cell (MSC)-based therapy has shown great promises in various animal disease models. However, this therapeutic potency has not been well claimed when applied to human clinical trials. This is due to both the availability of MSCs at the time of administration and lack of viable expansion strategies. MSCs are very susceptible to in vitro culture environment and tend to adapt the microenvironment which could lead to cellular senescence and aging. Therefore, extended in vitro expansion induces loss of MSC functionality and its clinical relevance. To combat this effect, this work assessed a novel cyclical aggregation as a means of expanding MSCs to maintain stem cell functionality. The cyclical aggregation consists of an aggregation phase and an expansion phase by replating the dissociated MSC aggregates onto planar tissue culture surfaces. The results indicate that cyclical aggregation maintains proliferative capability, stem cell proteins, and clonogenicity, and prevents the acquisition of senescence. To determine why aggregation was responsible for this phenomenon, the integrated stress response pathway was probed with salubrial and GSK-2606414. Treatment with salubrial had no significant effect, while GSK-2606414 mitigated the effects of aggregation leading to in vitro aging. This method holds the potential to increase the clinical relevance of MSC therapeutic effects from small model systems (such as rats and mice) to humans, and may open the potential of patient-derived MSCs for treatment thereby removing the need for immunosuppression.
format article
author Brent M. Bijonowski
Xuegang Yuan
Richard Jeske
Yan Li
Samuel C. Grant
author_facet Brent M. Bijonowski
Xuegang Yuan
Richard Jeske
Yan Li
Samuel C. Grant
author_sort Brent M. Bijonowski
title Cyclical aggregation extends in vitro expansion potential of human mesenchymal stem cells
title_short Cyclical aggregation extends in vitro expansion potential of human mesenchymal stem cells
title_full Cyclical aggregation extends in vitro expansion potential of human mesenchymal stem cells
title_fullStr Cyclical aggregation extends in vitro expansion potential of human mesenchymal stem cells
title_full_unstemmed Cyclical aggregation extends in vitro expansion potential of human mesenchymal stem cells
title_sort cyclical aggregation extends in vitro expansion potential of human mesenchymal stem cells
publisher Nature Portfolio
publishDate 2020
url https://doaj.org/article/482015429f474ea69540a7f3390f307c
work_keys_str_mv AT brentmbijonowski cyclicalaggregationextendsinvitroexpansionpotentialofhumanmesenchymalstemcells
AT xuegangyuan cyclicalaggregationextendsinvitroexpansionpotentialofhumanmesenchymalstemcells
AT richardjeske cyclicalaggregationextendsinvitroexpansionpotentialofhumanmesenchymalstemcells
AT yanli cyclicalaggregationextendsinvitroexpansionpotentialofhumanmesenchymalstemcells
AT samuelcgrant cyclicalaggregationextendsinvitroexpansionpotentialofhumanmesenchymalstemcells
_version_ 1718393855713214464